» Articles » PMID: 19701494

Cell Adhesion and Transcriptional Activity - Defining the Role of the Novel Protooncogene LPP

Overview
Journal Transl Oncol
Specialty Oncology
Date 2009 Aug 25
PMID 19701494
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Integrating signals from the extracellular matrix through the cell surface into the nucleus is an essential feature of metazoan life. To date, many signal transducers known as shuttle proteins have been identified to act as both a cytoskeletal and a signaling protein. Among them, the most prominent representatives are zyxin and lipoma preferred (translocation) partner (LPP). These proteins belong to the LIM domain protein family and are associated with cell migration, proliferation, and transcription. LPP was first identified in benign human lipomas and was subsequently found to be overexpressed in human malignancies such as lung carcinoma, soft tissue sarcoma, and leukemia. This review portrays LPP in the context of human neoplasia based on a study of the literature to define its important role as a novel protooncogene in carcinogenesis.

Citing Articles

PTPRK, an EGFR Phosphatase, Is Decreased in CeD Biopsies and Intestinal Organoids.

Nanayakkara M, Bellomo C, Furone F, Maglio M, Marano A, Lania G Cells. 2023; 12(1).

PMID: 36611909 PMC: 9818839. DOI: 10.3390/cells12010115.


Discovery of new therapeutic targets in ovarian cancer through identifying significantly non-mutated genes.

Al-Farsi H, Al-Azwani I, Malek J, Chouchane L, Rafii A, Halabi N J Transl Med. 2022; 20(1):244.

PMID: 35619151 PMC: 9134657. DOI: 10.1186/s12967-022-03440-5.


DEAD-Box Helicase 27 Triggers Epithelial to Mesenchymal Transition by Regulating Alternative Splicing of Lipoma-Preferred Partner in Gastric Cancer Metastasis.

Jin Y, Yang S, Gao X, Chen D, Luo T, Su S Front Genet. 2022; 13:836199.

PMID: 35601484 PMC: 9114675. DOI: 10.3389/fgene.2022.836199.


Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancer.

Wang H, Wu J, Ling R, Li F, Yang Q, He J Mol Ther Oncolytics. 2022; 24:547-560.

PMID: 35229032 PMC: 8857546. DOI: 10.1016/j.omto.2022.01.008.


Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 () and Nuclear Receptor Co-repressor 2 () in Osteoclastic Giant Cell-rich Tumors of Bone.

Panagopoulos I, Andersen K, Gorunova L, Lund-Iversen M, Lobmaier I, Heim S Cancer Genomics Proteomics. 2022; 19(2):163-177.

PMID: 35181586 PMC: 8865047. DOI: 10.21873/cgp.20312.


References
1.
Salvi A, Bongarzone I, Micciche F, Arici B, Barlati S, de Petro G . Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. Neoplasia. 2009; 11(2):207-19. PMC: 2631145. DOI: 10.1593/neo.81076. View

2.
Shepherd T, Kockeritz L, Szrajber M, Muller W, Hassell J . The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis. Curr Biol. 2001; 11(22):1739-48. DOI: 10.1016/s0960-9822(01)00536-x. View

3.
Drees B, Friederich E, Fradelizi J, Louvard D, Beckerle M, Golsteyn R . Characterization of the interaction between zyxin and members of the Ena/vasodilator-stimulated phosphoprotein family of proteins. J Biol Chem. 2000; 275(29):22503-11. DOI: 10.1074/jbc.M001698200. View

4.
von Ahsen I, Rogalla P, Bullerdiek J . Expression patterns of the LPP-HMGA2 fusion transcript in pulmonary chondroid hamartomas with t(3;12)(q27 approximately 28;q14 approximately 15). Cancer Genet Cytogenet. 2005; 163(1):68-70. DOI: 10.1016/j.cancergencyto.2005.02.023. View

5.
Romanos J, Barisani D, Trynka G, Zhernakova A, Bardella M, Wijmenga C . Six new coeliac disease loci replicated in an Italian population confirm association with coeliac disease. J Med Genet. 2008; 46(1):60-3. DOI: 10.1136/jmg.2008.061457. View